A listing of Dermatology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Join our ADDS-UP3 (Atopic Dermatitis Disparities Study – University of Pennsylvania & Philadelphia Partnership): Eczema Interview Study!The purpose of this study is to understand your experience living with eczema (also known as atopic dermatitis) and identify the things in your daily life that affect your skin. Study Details: Your participation in the …
The purpose of this study is to characterize gene mutations associated Central Centrifugal Cicatricial Alopecia (CCCA). The Penn Medicine BioBank (PMBB) supports researchers by providing centralized access to a large number of annotated blood and tissue samples. Clinician identified patients with CCCA and appropriate controls will be recruited from the …
This study aims to find out if a new investigational drug, vilobelimab (also called IFX-1) is safe and effective in treating subjects 18 and older diagnosed Ulcerative Pyoderma Gangrenosum. Procedures include blood and urine tests, a physical examination, vital signs, body weight and height, an electrocardiogram (ECG), and full assessment …
The purpose of this study is to determine if individuals diagnosed with palmoplantar pustulosis (PPP) would benefit from treatment with Deucravacitinib.
Determine the effect of clascoterone on clinical severity of PSD. Analyze the influence of clascoterone in disease-specific quality of life. Quantify the effect of clascoterone on surgical outcomes and cutaneous inflammation. 1. Medical photography with independent physician scores of PSD clinical severity at weeks 4, 8, and 12 on treatment …
Purpose is to determine if cemiplimab (given as infusion in the vein) will prevent cutaneous squamous cell cancer from returning after surgery and radiation. Subjects at least 18 years of age who have had surgery and radiation therapy for cutaneous squamous cell cancer, and there is a risk that this …
This is a multi-center Phase 3 study to evaluate the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair loss. The study is placebo-controlled, meaning that some patients entering the study will not receive active study …
The goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.
To access safety, tolerability, and preliminary efficacy of single subcutaneous (SC) dose of BxC-I17e in patients with moderate to severe atopic dermatitis (AD). The incidence of treatment-emergent adverse events (TEAEs) from baseline through Week 26 Adverse events, vital signs, physical examinations, 12-lead electrocardiograms (ECG) and laboratory parameters through Week 26. …
The project will estimate the prevalence of RV-associated cutaneous granulomas in normal adult population over a 15-year period and assess the frequency and intensity of virus shedding by these long-term RV carriers. These results will help ascertain the impact of long-term RV carriers that could influence the maintenance of rubella …